usecasehitident
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revisionNext revision | Previous revision | ||
| usecasehitident [2013/10/09 08:39] – rkiss | usecasehitident [2014/01/01 15:49] (current) – flack | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== | + | ====== |
| - | [[http:// | + | [[http:// |
| - | You can identify new inhibitors/ | + | You can identify new inhibitors/ |
| - | **__[[usecasestrbased|Structure-based virtual screening | + | **[[usecasestrbased|Structure-based virtual screening |
| - | **__[[usecaseligbased|Ligand-based virtual screening | + | **[[usecaseligbased|Ligand-based virtual screening |
| + | -- | ||
| - | ====== Ligand-based virtual screening ====== | + | **[[usecases|Go back to use cases »]]** |
| - | + | ||
| - | Ligand-based virtual screening does not utilize the 3D structure of the target when searching for new hits. Instead, it is based on the structure of a reference ligand (endogenous ligand, known inhibitor, etc.) that binds to a target and/or exhibits some beneficial effect. In ligand-based virtual screening, compounds are typically ranked based on the similarity to the reference ligand (query). | + | |
| - | + | ||
| - | **__[[usecases|Go back to use cases >>]]__** | + | |
usecasehitident.1381307993.txt.gz · Last modified: by rkiss